Chemoinformaics analysis of INDOLE-3-ACETIC-ACID-METHYL-ESTER
| Molecular Weight | 203.241 | nRot | 4 |
| Heavy Atom Molecular Weight | 190.137 | nRig | 11 |
| Exact Molecular Weight | 203.095 | nRing | 2 |
| Solubility: LogS | -2.868 | nHRing | 1 |
| Solubility: LogP | 2.329 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 13 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 9 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 10 |
| nHA | 1 | APOL | 31.4123 |
| nHD | 2 | BPOL | 14.4797 |
| QED | 0.802 |
| Synth | 1.749 |
| Natural Product Likeliness | 0.118 |
| NR-PPAR-gamma | 0.944 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.002 |
| HIA | 0.006 |
| CACO-2 | -4.547 |
| MDCK | 0.0000116 |
| BBB | 0.29 |
| PPB | 0.930717 |
| VDSS | 0.239 |
| FU | 0.0530616 |
| CYP1A2-inh | 0.25 |
| CYP1A2-sub | 0.501 |
| CYP2c19-inh | 0.086 |
| CYP2c19-sub | 0.063 |
| CYP2c9-inh | 0.047 |
| CYP2c9-sub | 0.97 |
| CYP2d6-inh | 0.137 |
| CYP2d6-sub | 0.785 |
| CYP3a4-inh | 0.015 |
| CYP3a4-sub | 0.064 |
| CL | 4.48 |
| T12 | 0.909 |
| hERG | 0.027 |
| Ames | 0.01 |
| ROA | 0.684 |
| SkinSen | 0.466 |
| Carcinogencity | 0.175 |
| EI | 0.905 |
| Respiratory | 0.465 |
| NR-Aromatase | 0.256 |
| Antiviral | No |
| Prediction | 0.670138 |